Merck & Co News

Possible Bearish Signals With Merck Insiders Disposing Stock

Over the past year, many Merck & Co., Inc. (NYSE:MRK) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whethe

Simply Wall St12:26 ET

Why Merck (MRK) Is a Top Momentum Stock for the Long-Term

Yahoo FinanceMay 22 09:50 ET

Merck & Co., Inc. (NYSE:MRK) Is a Favorite Amongst Institutional Investors Who Own 79%

Yahoo FinanceMay 22 07:00 ET

Dragonfly Therapeutics, Inc., Gibt Klinische Zusammenarbeit Zur Evaluierung Von DF9001, Einem EGFR-Targeting TriNKET, in Kombination Mit KEYTRUDA (Pembrolizumab) Bei Patienten Mit Soliden Tumoren Bekannt

DF9001 wird derzeit als Monotherapie für die Behandlung von nicht-kleinzelligem Lungenkrebs, Nierenzellkarzinom und Plattenepithelkarzinom im Kopf- und Halsbereich geprüft. Die Zusammenarbeit im Ra

PR NewswireMay 22 00:25 ET

Dragonfly Therapeutics, Inc. Annonce Une Collaboration Clinique Pour Évaluer Le DF9001, Un TriNKET Ciblant EGFR, En Association Avec KEYTRUDA (Pembrolizumab) Chez Les Patients Atteints De Tumeurs Solides

Le DF9001 est actuellement évalué en monothérapie pour le traitement du cancer du poumon non à petites cellules, du carcinome rénal et du carcinome épidermoïde de la tête et du cou. La collab

PR NewswireMay 22 00:23 ET

Express News | NYSE Order Imbalance 181968.0 Shares on Buy Side

ReutersMay 21 15:50 ET

Performance Comparison: Merck & Co And Competitors In Pharmaceuticals Industry

In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies before making investment decisions. In this article, we

BenzingaMay 21 11:00 ET

Express News | Dragonfly Therapeutics: Clinical Trial Sites Currently Open for Monotherapy Dosing in U.S., With Extra Sites in North America & Europe to Open in 2024

ReutersMay 21 07:05 ET

Express News | Dragonfly Therapeutics: First Patients Expected to Receive Df9001 in Combination With Pembrolizumab in Q4 2024

ReutersMay 21 07:04 ET

Express News | Dragonfly Therapeutics: Clinical Collaboration With Merck to Evaluate Df9001 in Combination With Keytruda

ReutersMay 21 07:04 ET

Dragonfly Therapeutics, Inc. Announces Clinical Collaboration to Evaluate DF9001, an EGFR Targeting TriNKET, in Combination With KEYTRUDA (Pembrolizumab) in Patients With Solid Tumors

DF9001 is currently being evaluated as a monotherapy for the treatment of Non-Small Cell Lung Cancer, Renal Cell Carcinoma and Head and Neck Squamous Cell Carcinoma. The clinical trial collaboration

PR NewswireMay 21 07:00 ET

Express News | NYSE Order Imbalance 197346.0 Shares on Buy Side

ReutersMay 20 15:50 ET

Here's Why Merck (MRK) Stock Has Outperformed Industry YTD

Yahoo FinanceMay 20 09:14 ET

The Zacks Analyst Blog Highlights Stocks Recently Featured in the Blog Include: American Express, Walmart, Amazon, The Goldman Sachs and Merck & Co

Yahoo FinanceMay 20 06:49 ET

Are LLY.US (LLY.US) and Novo Nordisk (NVO.US) currently overvalued?

The Zhitong Finance App learned that the stock prices of LLY.US (LLY.US) and Novo Nordisk (NVO.US) have continued to rise in recent months, mainly due to a surge in demand for the weight loss or diabetes drugs tizapatide (also known as Zepbound) and simeglutide (also known as Wegovy) produced by the two giants. Over the past year, Eli Lilly's shares soared 76%, while Novo Nordisk jumped 58%. By contrast, the S&P 500 rose 28% by the close of May 17. Meanwhile, other stocks of major pharmaceutical companies have had mixed feelings. Over the past year, GlaxoSmithKline (G

Zhitong FinanceMay 19 22:58 ET

Express News | NYSE Order Imbalance 450538.0 Shares on Buy Side

ReutersMay 17 15:50 ET

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

BenzingaMay 17 13:35 ET

5 Stocks Powering the Dow ETF Year to Date

The Dow Jones Industrial Average touched the milestone of 40,000 for the first time on strong corporate earnings and renewed bets for rate cuts.

Yahoo FinanceMay 17 11:10 ET

Express News | NYSE Order Imbalance 293446.0 Shares on Buy Side

ReutersMay 16 15:50 ET

Check Out What Whales Are Doing With MRK

Investors with a lot of money to spend have taken a bullish stance on Merck & Co (NYSE:MRK).And retail traders should know.We noticed this today when the trades showed up on publicly available options

BenzingaMay 16 14:36 ET